Hemp, Inc
Hemp, Inc HEMP Peers
See (HEMP) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HEMP | $0.00 | +100.00% | 17.7K | -0.05 | -$0.00 | N/A |
| MKGAF | $132.80 | +3.90% | 57.7B | 17.80 | $7.46 | +1.70% |
| MKKGY | $26.04 | +2.64% | 57.1B | 17.48 | $1.49 | +2.23% |
| HLNCF | $5.25 | +1.16% | 47.2B | 24.98 | $0.21 | +1.17% |
| TKPHF | $28.35 | +2.42% | 44.6B | 60.32 | $0.47 | +4.81% |
| IPSEY | $29.78 | +3.91% | 39.4B | 24.41 | $1.22 | +0.75% |
| SDZNY | $52.66 | -1.42% | 22.7B | -2633.00 | -$0.02 | +1.28% |
| TEVJF | $17.80 | N/A | 20.4B | -15.48 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| SGIOF | $17.63 | N/A | 15B | 12.77 | $1.38 | +2.36% |
Stock Comparison
HEMP vs MKGAF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, MKGAF has a market cap of 57.7B. Regarding current trading prices, HEMP is priced at $0.00, while MKGAF trades at $132.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas MKGAF's P/E ratio is 17.80. In terms of profitability, HEMP's ROE is -0.39%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, HEMP is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs MKKGY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, MKKGY has a market cap of 57.1B. Regarding current trading prices, HEMP is priced at $0.00, while MKKGY trades at $26.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas MKKGY's P/E ratio is 17.48. In terms of profitability, HEMP's ROE is -0.39%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, HEMP is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs HLNCF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HLNCF has a market cap of 47.2B. Regarding current trading prices, HEMP is priced at $0.00, while HLNCF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HLNCF's P/E ratio is 24.98. In terms of profitability, HEMP's ROE is -0.39%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, HEMP is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs TKPHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, TKPHF has a market cap of 44.6B. Regarding current trading prices, HEMP is priced at $0.00, while TKPHF trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas TKPHF's P/E ratio is 60.32. In terms of profitability, HEMP's ROE is -0.39%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, HEMP and TKPHF have similar daily volatility (0.00).
HEMP vs IPSEY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, IPSEY has a market cap of 39.4B. Regarding current trading prices, HEMP is priced at $0.00, while IPSEY trades at $29.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas IPSEY's P/E ratio is 24.41. In terms of profitability, HEMP's ROE is -0.39%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, HEMP is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs SDZNY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SDZNY has a market cap of 22.7B. Regarding current trading prices, HEMP is priced at $0.00, while SDZNY trades at $52.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SDZNY's P/E ratio is -2633.00. In terms of profitability, HEMP's ROE is -0.39%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, HEMP is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs TEVJF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, TEVJF has a market cap of 20.4B. Regarding current trading prices, HEMP is priced at $0.00, while TEVJF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas TEVJF's P/E ratio is -15.48. In terms of profitability, HEMP's ROE is -0.39%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, HEMP is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs ESALY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, HEMP is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas ESALY's P/E ratio is 20.54. In terms of profitability, HEMP's ROE is -0.39%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, HEMP is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs SGIOF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SGIOF has a market cap of 15B. Regarding current trading prices, HEMP is priced at $0.00, while SGIOF trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SGIOF's P/E ratio is 12.77. In terms of profitability, HEMP's ROE is -0.39%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, HEMP is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs SGIOY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SGIOY has a market cap of 14.9B. Regarding current trading prices, HEMP is priced at $0.00, while SGIOY trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SGIOY's P/E ratio is 12.68. In terms of profitability, HEMP's ROE is -0.39%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, HEMP is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs IPSEF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, HEMP is priced at $0.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas IPSEF's P/E ratio is 22.99. In terms of profitability, HEMP's ROE is -0.39%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, HEMP is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs BIOVF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, BIOVF has a market cap of 9.3B. Regarding current trading prices, HEMP is priced at $0.00, while BIOVF trades at $27.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas BIOVF's P/E ratio is 22.55. In terms of profitability, HEMP's ROE is -0.39%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, HEMP is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs ESALF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, ESALF has a market cap of 8.3B. Regarding current trading prices, HEMP is priced at $0.00, while ESALF trades at $29.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas ESALF's P/E ratio is 25.94. In terms of profitability, HEMP's ROE is -0.39%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, HEMP is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs SFOSF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SFOSF has a market cap of 8.2B. Regarding current trading prices, HEMP is priced at $0.00, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, HEMP's ROE is -0.39%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, HEMP is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs ESAIY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, ESAIY has a market cap of 7.8B. Regarding current trading prices, HEMP is priced at $0.00, while ESAIY trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas ESAIY's P/E ratio is 24.41. In terms of profitability, HEMP's ROE is -0.39%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, HEMP is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs HKMPY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HKMPY has a market cap of 6.2B. Regarding current trading prices, HEMP is priced at $0.00, while HKMPY trades at $56.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HKMPY's P/E ratio is 17.45. In terms of profitability, HEMP's ROE is -0.39%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, HEMP is less volatile compared to HKMPY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs HKMPF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HKMPF has a market cap of 6.1B. Regarding current trading prices, HEMP is priced at $0.00, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, HEMP's ROE is -0.39%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, HEMP is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs GZPHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, GZPHF has a market cap of 5.6B. Regarding current trading prices, HEMP is priced at $0.00, while GZPHF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas GZPHF's P/E ratio is 9.57. In terms of profitability, HEMP's ROE is -0.39%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, HEMP is less volatile compared to GZPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs WIBFF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, HEMP is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, HEMP's ROE is -0.39%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, HEMP is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs HLBBF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HLBBF has a market cap of 4.2B. Regarding current trading prices, HEMP is priced at $0.00, while HLBBF trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HLBBF's P/E ratio is 10.49. In terms of profitability, HEMP's ROE is -0.39%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, HEMP is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs LVZPF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, LVZPF has a market cap of 3.7B. Regarding current trading prices, HEMP is priced at $0.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, HEMP's ROE is -0.39%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, HEMP is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs HLUBF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HLUBF has a market cap of 3.6B. Regarding current trading prices, HEMP is priced at $0.00, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HLUBF's P/E ratio is 7.25. In terms of profitability, HEMP's ROE is -0.39%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, HEMP is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs ULIHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, HEMP is priced at $0.00, while ULIHF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas ULIHF's P/E ratio is 9.25. In terms of profitability, HEMP's ROE is -0.39%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, HEMP and ULIHF have similar daily volatility (0.00).
HEMP vs APNHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, HEMP is priced at $0.00, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas APNHF's P/E ratio is 12.72. In terms of profitability, HEMP's ROE is -0.39%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, HEMP is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs INVVY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, HEMP is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas INVVY's P/E ratio is -62.42. In terms of profitability, HEMP's ROE is -0.39%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, HEMP and INVVY have similar daily volatility (0.00).
HEMP vs APNHY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, APNHY has a market cap of 2.9B. Regarding current trading prices, HEMP is priced at $0.00, while APNHY trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas APNHY's P/E ratio is 11.57. In terms of profitability, HEMP's ROE is -0.39%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, HEMP and APNHY have similar daily volatility (0.00).
HEMP vs IZQVF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, HEMP is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, HEMP's ROE is -0.39%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, HEMP and IZQVF have similar daily volatility (0.00).
HEMP vs HYPMY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HYPMY has a market cap of 2.8B. Regarding current trading prices, HEMP is priced at $0.00, while HYPMY trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HYPMY's P/E ratio is 19.57. In terms of profitability, HEMP's ROE is -0.39%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, HEMP is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs HMDCF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, HEMP is priced at $0.00, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, HEMP's ROE is -0.39%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, HEMP is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs DNPUF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, DNPUF has a market cap of 2.6B. Regarding current trading prices, HEMP is priced at $0.00, while DNPUF trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas DNPUF's P/E ratio is 15.95. In terms of profitability, HEMP's ROE is -0.39%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, HEMP and DNPUF have similar daily volatility (0.00).
HEMP vs SMDPY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SMDPY has a market cap of 2.4B. Regarding current trading prices, HEMP is priced at $0.00, while SMDPY trades at $6.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SMDPY's P/E ratio is 14.83. In terms of profitability, HEMP's ROE is -0.39%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, HEMP is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs THCBF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, HEMP is priced at $0.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas THCBF's P/E ratio is -0.10. In terms of profitability, HEMP's ROE is -0.39%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, HEMP is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs CHSYF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, HEMP is priced at $0.00, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, HEMP's ROE is -0.39%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, HEMP and CHSYF have similar daily volatility (0.00).
HEMP vs TSMRF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, HEMP is priced at $0.00, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, HEMP's ROE is -0.39%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, HEMP and TSMRF have similar daily volatility (0.00).
HEMP vs DMPHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, HEMP is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, HEMP's ROE is -0.39%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, HEMP and DMPHF have similar daily volatility (0.00).
HEMP vs HTSUF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, HEMP is priced at $0.00, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HTSUF's P/E ratio is 14.19. In terms of profitability, HEMP's ROE is -0.39%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, HEMP is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs LJUIF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, HEMP is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, HEMP's ROE is -0.39%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, HEMP and LJUIF have similar daily volatility (0.00).
HEMP vs LBTSF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, LBTSF has a market cap of 1.9B. Regarding current trading prices, HEMP is priced at $0.00, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, HEMP's ROE is -0.39%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, HEMP is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs ARSUF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, HEMP is priced at $0.00, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, HEMP's ROE is -0.39%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, HEMP and ARSUF have similar daily volatility (0.00).
HEMP vs NPNKF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, HEMP is priced at $0.00, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas NPNKF's P/E ratio is 7.66. In terms of profitability, HEMP's ROE is -0.39%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, HEMP is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs YIHCF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, HEMP is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, HEMP's ROE is -0.39%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, HEMP and YIHCF have similar daily volatility (0.00).
HEMP vs MITPF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, HEMP is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas MITPF's P/E ratio is -10.81. In terms of profitability, HEMP's ROE is -0.39%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, HEMP is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs KARBF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, HEMP is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas KARBF's P/E ratio is 262.50. In terms of profitability, HEMP's ROE is -0.39%, compared to KARBF's ROE of N/A. Regarding short-term risk, HEMP and KARBF have similar daily volatility (0.00).
HEMP vs EVOTF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, HEMP is priced at $0.00, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, HEMP's ROE is -0.39%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, HEMP is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs NPPNY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, HEMP is priced at $0.00, while NPPNY trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas NPPNY's P/E ratio is 6.43. In terms of profitability, HEMP's ROE is -0.39%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, HEMP is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs SHEZF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, HEMP is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, HEMP's ROE is -0.39%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, HEMP is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs CHIZF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CHIZF has a market cap of 1.2B. Regarding current trading prices, HEMP is priced at $0.00, while CHIZF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CHIZF's P/E ratio is 12.00. In terms of profitability, HEMP's ROE is -0.39%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, HEMP is less volatile compared to CHIZF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs GTBIF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, HEMP is priced at $0.00, while GTBIF trades at $4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas GTBIF's P/E ratio is 23.76. In terms of profitability, HEMP's ROE is -0.39%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, HEMP is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs KSPHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, HEMP is priced at $0.00, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas KSPHF's P/E ratio is 14.28. In terms of profitability, HEMP's ROE is -0.39%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, HEMP is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs SWGHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, HEMP is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, HEMP's ROE is -0.39%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, HEMP and SWGHF have similar daily volatility (0.00).
HEMP vs GNMLF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, HEMP is priced at $0.00, while GNMLF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas GNMLF's P/E ratio is 9.50. In terms of profitability, HEMP's ROE is -0.39%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, HEMP and GNMLF have similar daily volatility (0.00).
HEMP vs KKPCF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, HEMP is priced at $0.00, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, HEMP's ROE is -0.39%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, HEMP is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs CASBF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CASBF has a market cap of 985.3M. Regarding current trading prices, HEMP is priced at $0.00, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CASBF's P/E ratio is -15.24. In terms of profitability, HEMP's ROE is -0.39%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, HEMP is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs SHPHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, HEMP is priced at $0.00, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, HEMP's ROE is -0.39%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, HEMP is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs LVTTF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, LVTTF has a market cap of 904M. Regarding current trading prices, HEMP is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, HEMP's ROE is -0.39%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, HEMP is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs BIOGY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, HEMP is priced at $0.00, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, HEMP's ROE is -0.39%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, HEMP is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs NRXCF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, NRXCF has a market cap of 846.4M. Regarding current trading prices, HEMP is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, HEMP's ROE is -0.39%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, HEMP and NRXCF have similar daily volatility (0.00).
HEMP vs TWAPF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, HEMP is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, HEMP's ROE is -0.39%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, HEMP is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs ELTP Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, ELTP has a market cap of 827.8M. Regarding current trading prices, HEMP is priced at $0.00, while ELTP trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas ELTP's P/E ratio is -38.74. In terms of profitability, HEMP's ROE is -0.39%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, HEMP is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs CSWYF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, HEMP is priced at $0.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, HEMP's ROE is -0.39%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, HEMP is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs TRXPF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, HEMP is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, HEMP's ROE is -0.39%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, HEMP and TRXPF have similar daily volatility (0.00).
HEMP vs TCNNF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, TCNNF has a market cap of 663M. Regarding current trading prices, HEMP is priced at $0.00, while TCNNF trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas TCNNF's P/E ratio is -4.39. In terms of profitability, HEMP's ROE is -0.39%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, HEMP is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs SWDCF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SWDCF has a market cap of 655.3M. Regarding current trading prices, HEMP is priced at $0.00, while SWDCF trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SWDCF's P/E ratio is 68.33. In terms of profitability, HEMP's ROE is -0.39%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, HEMP is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs TRSSF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, HEMP is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, HEMP's ROE is -0.39%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, HEMP is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs CURLF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CURLF has a market cap of 590.8M. Regarding current trading prices, HEMP is priced at $0.00, while CURLF trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CURLF's P/E ratio is -2.36. In terms of profitability, HEMP's ROE is -0.39%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, HEMP is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs SGFEF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, SGFEF has a market cap of 583.8M. Regarding current trading prices, HEMP is priced at $0.00, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas SGFEF's P/E ratio is 25.19. In terms of profitability, HEMP's ROE is -0.39%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, HEMP is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs PKBFF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, PKBFF has a market cap of 545.6M. Regarding current trading prices, HEMP is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas PKBFF's P/E ratio is N/A. In terms of profitability, HEMP's ROE is -0.39%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, HEMP and PKBFF have similar daily volatility (0.00).
HEMP vs CCHWF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, HEMP is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, HEMP's ROE is -0.39%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, HEMP is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs BOIRF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, HEMP is priced at $0.00, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, HEMP's ROE is -0.39%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, HEMP is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs PEXXF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, HEMP is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, HEMP's ROE is -0.39%, compared to PEXXF's ROE of N/A. Regarding short-term risk, HEMP and PEXXF have similar daily volatility (0.00).
HEMP vs KHTRF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, KHTRF has a market cap of 442.3M. Regarding current trading prices, HEMP is priced at $0.00, while KHTRF trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas KHTRF's P/E ratio is 63.43. In terms of profitability, HEMP's ROE is -0.39%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, HEMP is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs AGYTF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, HEMP is priced at $0.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, HEMP's ROE is -0.39%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, HEMP is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs HUMDF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, HEMP is priced at $0.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, HEMP's ROE is -0.39%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, HEMP and HUMDF have similar daily volatility (0.00).
HEMP vs AIHLF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, AIHLF has a market cap of 396.2M. Regarding current trading prices, HEMP is priced at $0.00, while AIHLF trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas AIHLF's P/E ratio is 8.45. In terms of profitability, HEMP's ROE is -0.39%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, HEMP and AIHLF have similar daily volatility (0.00).
HEMP vs NIKA Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, NIKA has a market cap of 318.2M. Regarding current trading prices, HEMP is priced at $0.00, while NIKA trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas NIKA's P/E ratio is N/A. In terms of profitability, HEMP's ROE is -0.39%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, HEMP and NIKA have similar daily volatility (0.00).
HEMP vs BHCCF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, BHCCF has a market cap of 271.2M. Regarding current trading prices, HEMP is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, HEMP's ROE is -0.39%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, HEMP is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs GLASF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, GLASF has a market cap of 264M. Regarding current trading prices, HEMP is priced at $0.00, while GLASF trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas GLASF's P/E ratio is -54.78. In terms of profitability, HEMP's ROE is -0.39%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, HEMP is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs CPHRF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CPHRF has a market cap of 240.9M. Regarding current trading prices, HEMP is priced at $0.00, while CPHRF trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CPHRF's P/E ratio is 26.11. In terms of profitability, HEMP's ROE is -0.39%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, HEMP is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs PLNHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, HEMP is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, HEMP's ROE is -0.39%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, HEMP is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs AUSAF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, AUSAF has a market cap of 193.4M. Regarding current trading prices, HEMP is priced at $0.00, while AUSAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas AUSAF's P/E ratio is -0.09. In terms of profitability, HEMP's ROE is -0.39%, compared to AUSAF's ROE of -1.15%. Regarding short-term risk, HEMP and AUSAF have similar daily volatility (0.00).
HEMP vs VRNOF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, VRNOF has a market cap of 171.5M. Regarding current trading prices, HEMP is priced at $0.00, while VRNOF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas VRNOF's P/E ratio is -0.48. In terms of profitability, HEMP's ROE is -0.39%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, HEMP is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs CRLBF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CRLBF has a market cap of 154M. Regarding current trading prices, HEMP is priced at $0.00, while CRLBF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CRLBF's P/E ratio is -1.90. In terms of profitability, HEMP's ROE is -0.39%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, HEMP is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs CBSTF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CBSTF has a market cap of 151M. Regarding current trading prices, HEMP is priced at $0.00, while CBSTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CBSTF's P/E ratio is -0.21. In terms of profitability, HEMP's ROE is -0.39%, compared to CBSTF's ROE of +10.11%. Regarding short-term risk, HEMP is less volatile compared to CBSTF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs PHCUF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, PHCUF has a market cap of 138.3M. Regarding current trading prices, HEMP is priced at $0.00, while PHCUF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas PHCUF's P/E ratio is 519.00. In terms of profitability, HEMP's ROE is -0.39%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, HEMP and PHCUF have similar daily volatility (0.00).
HEMP vs COPHF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, HEMP is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas COPHF's P/E ratio is -0.02. In terms of profitability, HEMP's ROE is -0.39%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, HEMP is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs HLTRF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, HLTRF has a market cap of 115.8M. Regarding current trading prices, HEMP is priced at $0.00, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas HLTRF's P/E ratio is -6.42. In terms of profitability, HEMP's ROE is -0.39%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, HEMP and HLTRF have similar daily volatility (0.00).
HEMP vs LPCUF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, HEMP is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, HEMP's ROE is -0.39%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, HEMP and LPCUF have similar daily volatility (0.00).
HEMP vs CNVCF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, HEMP is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, HEMP's ROE is -0.39%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, HEMP and CNVCF have similar daily volatility (0.00).
HEMP vs NWPN Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, NWPN has a market cap of 100.8M. Regarding current trading prices, HEMP is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas NWPN's P/E ratio is -0.03. In terms of profitability, HEMP's ROE is -0.39%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, HEMP is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs BIOYF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, BIOYF has a market cap of 97.5M. Regarding current trading prices, HEMP is priced at $0.00, while BIOYF trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas BIOYF's P/E ratio is 17.35. In terms of profitability, HEMP's ROE is -0.39%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, HEMP and BIOYF have similar daily volatility (0.00).
HEMP vs LOVFF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, LOVFF has a market cap of 94.4M. Regarding current trading prices, HEMP is priced at $0.00, while LOVFF trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas LOVFF's P/E ratio is 10.33. In terms of profitability, HEMP's ROE is -0.39%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, HEMP is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs LRDSF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, LRDSF has a market cap of 84.2M. Regarding current trading prices, HEMP is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, HEMP's ROE is -0.39%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, HEMP is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs GBLP Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, GBLP has a market cap of 83M. Regarding current trading prices, HEMP is priced at $0.00, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas GBLP's P/E ratio is -0.67. In terms of profitability, HEMP's ROE is -0.39%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, HEMP and GBLP have similar daily volatility (0.00).
HEMP vs CBWTF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, CBWTF has a market cap of 81.6M. Regarding current trading prices, HEMP is priced at $0.00, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas CBWTF's P/E ratio is 3.10. In terms of profitability, HEMP's ROE is -0.39%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, HEMP is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs GRUSF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, GRUSF has a market cap of 79.3M. Regarding current trading prices, HEMP is priced at $0.00, while GRUSF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas GRUSF's P/E ratio is -6.40. In terms of profitability, HEMP's ROE is -0.39%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, HEMP is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs MEDXF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, MEDXF has a market cap of 77.1M. Regarding current trading prices, HEMP is priced at $0.00, while MEDXF trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas MEDXF's P/E ratio is 15.93. In terms of profitability, HEMP's ROE is -0.39%, compared to MEDXF's ROE of +0.11%. Regarding short-term risk, HEMP is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs DUTV Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, DUTV has a market cap of 75.3M. Regarding current trading prices, HEMP is priced at $0.00, while DUTV trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas DUTV's P/E ratio is N/A. In terms of profitability, HEMP's ROE is -0.39%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, HEMP is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs ABSCF Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, ABSCF has a market cap of 74.8M. Regarding current trading prices, HEMP is priced at $0.00, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, HEMP's ROE is -0.39%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, HEMP is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for HEMP.
HEMP vs EOFBY Comparison
HEMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HEMP stands at 17.7K. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, HEMP is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HEMP currently has a P/E ratio of -0.05, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, HEMP's ROE is -0.39%, compared to EOFBY's ROE of N/A. Regarding short-term risk, HEMP and EOFBY have similar daily volatility (0.00).